⌘K

Home/Filings/4/0001235802-21-000127

4//SEC Filing

Bandy Barton P. 4

Accession 0001235802-21-000127

CIK 0001427570other

View on SEC.gov Company Profile

Filed

Oct 11, 8:00 PM ET

Accepted

Oct 12, 7:35 PM ET

Size

4.7 KB

Accession

0001235802-21-000127

Insider Transaction Report

Form 4

Period: 2021-10-01

ReShape Lifesciences Inc.RSLS

Bandy Barton P.

DirectorPresident and CEO

Transactions

Sale
Common Stock, $0.001 par value per share
2021-10-01$2.77/sh−12,565$34,805→ 878,947 total

Footnotes (1)

[F1]These shares were sold to cover taxes in connection with the vesting of restricted stock units.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

ReShape Lifesciences Inc.

CIK 0001427570

Entity typeother

Related Parties

1

filerCIK 0001773309

Filing Metadata

Form type: 4
Filed: Oct 11, 8:00 PM ET
Accepted: Oct 12, 7:35 PM ET
Size: 4.7 KB

View on SEC.gov